Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 8 views

    Cedric Bisson - Investors Brief

    Uploaded by

    Leyy
    This document provides information about Cedric Bisson, a partner at Teralys Capital who focuses on life sciences and healthcare investments. It outlines his background, experience, roles, and education. Key details include his MD from McGill University and JD from Université de Montréal, his current role leading healthcare investments at Teralys Capital, and past board roles and investments in companies focused on areas like biopharmaceuticals and medical devices.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Cedric Bisson - Investors Brief

    Uploaded by

    Leyy
    8 views3 pages
    This document provides information about Cedric Bisson, a partner at Teralys Capital who focuses on life sciences and healthcare investments. It outlines his background, experience, roles, and education. Key details include his MD from McGill University and JD from Université de Montréal, his current role leading healthcare investments at Teralys Capital, and past board roles and investments in companies focused on areas like biopharmaceuticals and medical devices.

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document provides information about Cedric Bisson, a partner at Teralys Capital who focuses on life sciences and healthcare investments. It outlines his background, experience, roles, and education. Key details include his MD from McGill University and JD from Université de Montréal, his current role leading healthcare investments at Teralys Capital, and past board roles and investments in companies focused on areas like biopharmaceuticals and medical devices.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    8 views3 pages

    Cedric Bisson - Investors Brief

    Uploaded by

    Leyy
    This document provides information about Cedric Bisson, a partner at Teralys Capital who focuses on life sciences and healthcare investments. It outlines his background, experience, roles, and education. Key details include his MD from McGill University and JD from Université de Montréal, his current role leading healthcare investments at Teralys Capital, and past board roles and investments in companies focused on areas like biopharmaceuticals and medical devices.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    You are on page 1of 3

    Created by: Rheil De Guzman

    Date Created: May 18, 2024


    Last Modified: May 18, 2024 by

    Innovestor Life Science


    - Investment Thesis: Focused on building and investing in clinically meaningful opportunities
    in biopharmaceuticals, medical devices and related areas.
    - Most Recent Fund: Teralys Capital Innovation Fund 2023
    - Investment Strategy: Biopharmaceuticals & Healthcare
    - Investment Criteria:
    - Emphasis on disruptive technologies.
    - Scalability.
    - Strong management teams.
    - Investment Stage: From early-stage start-ups to growth and expansion.
    - Average Investment Size:
    - Target geographics: Canada and the United States.
    - Total # of Investments: Over 230.
    - Total # of Portfolio Companies: Over 230.
    - Relevant Biotech/Health Portfolio Companies:
    - General Observations: Focus on fostering innovation in the life sciences and
    technology sectors by creating, building, advising and investing in businesses in
    biopharmaceuticals, healthcare and the innovation sector in general.
    - Mimetogen Pharmaceuticals - Is a Phase III clinical stage biotechnology
    company focused on developing the use of peptidomimetics as a novel
    approach to treating ophthalmic diseases with high unmet medical needs.
    - BaroSense, Inc. - is a medical device compan, that focuses on the research
    and development of innovative, minimally invasive medical devices for the
    treatment of obesity.
    - Milestone Pharmaceuticals, Inc. - Aims to provide a sense of security to
    patients with PSVT and other episodic cardiovascular conditions through its
    investigational therapies.
    - Resonant Medical - Develops, manufactures and commercializes 3D
    ultrasound image-guided adaptive radiotherapy products.
    Cedric Bisson
    Partner at Teralys Capital
    Montreal, Quebec, Canada
    LinkedIn

    Executive Summary:
    - Entrepreneur and Investor that focuses on life sciences and healthcare investments, as well
    as growth opportunities. His specialized expertise and network in life sciences contribute
    greatly to the execution of Teralys' investment strategy in this sector.
    - Expert in creating, building, advising and investing in businesses in biopharmaceuticals,
    healthcare and the innovation sector in general.
    - M.D. degree from McGill University and a J.D. (law) degree from Université de Montréal.

    Current Role:
    - Partner at Teralys Capital (2011 - Present)
    - Focuses on life sciences and healthcare investments.
    - Leads growth and expansion opportunities within the firm.

    Board Member/Observer:
    - Mimetogen Pharmaceuticals (Jan 2006 - Present) - Is a Phase III clinical stage biotechnology
    company focused on developing the use of peptidomimetics as a novel approach to treating
    ophthalmic diseases with high unmet medical needs.
    - PROCURE ALLIANCE (2009 - Present) – is Quebec's largest charity fighting prostate cancer
    by means of education and awareness programs for men and their families, as well as the
    financing of research leveraging a proprietary world-class Biobank of biological materials
    and data to accelerate the discovery and development of new cures against prostate cancer.
    - Board Member and Investment Committee Member at Grand Challenges Canada (Mar 2013
    - Present) – supports integrate science and technology, social and business innovation.

    Previous Roles:
    - Committee Member, Accel-Rx - Canada's Health Science Accelerator (2016-2020)
    - Chairman, La Biennale de Montréal (2013 - 2018)
    - Board Observer, BaroSense, Inc. (2009 - 2013)
    - Board Member, Milestone Pharmaceuticals, Inc. (2006 - 2011)
    - Managing Partner, iNovia Capital (2003 - 2011)
    - Founder & Investment Committee Member, MSBi Valorisation (2003 - 2011)
    - Board Member, Resonant Medical (2003 - 2010
    - Associate Principal, McKinsey & Company (1997 - 2003)
    Education:
    - Bachelor of Laws (LL.B.) - Université de Montréal (1991 – 1994)
    - Medicine (M.D.) - McGill University (1986 – 1991)
    - Diploma of Collegiate Studies - College Jean-de-Brebeuf

    You might also like